# The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis

> **NCT02306187** · PHASE1 · UNKNOWN · sponsor: **Shinshu University** · enrollment: 100 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Edirol

## Key facts

- **NCT ID:** NCT02306187
- **Lead sponsor:** Shinshu University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2022-12
- **Final completion:** 2024-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306187, "The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02306187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*